Lack of Tacrolimus Circadian Pharmacokinetics and CYP3A5 Pharmacogenetics in the Early and Maintenance Stages in Renal Transplant Recipients.

被引：0
|
作者：
Satoh, Shigeru [1 ]
Saito, Mitsuru [1 ]
Kagaya, Hideaki [2 ]
Miura, Masatomo [2 ]
Inoue, Takamitsu [1 ]
Miura, Yoshio [1 ]
Numakura, Kazuyuki [1 ]
Kumazawa, Teruaki [1 ]
Tsuchiya, Norihiko [1 ]
Habuchi, Tomonori [1 ]
机构：
[1] Akita Univ, Sch Med, Akita 010, Japan
[2] Akita Univ Hosp, Akita, Japan
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2009年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：590 / 590
页数：1
相关论文
共 50 条
  • [1] Lack of tacrolimus circadian pharmacokinetics and CYP3A5 pharmacogenetics in the early and maintenance stages in Japanese renal transplant recipients
    Satoh, Shigeru
    Kagaya, Hideaki
    Saito, Mitsuru
    Inoue, Takamitsu
    Miura, Masatomo
    Inoue, Kazuyuki
    Numakura, Kazuyuki
    Tsuchiya, Norihiko
    Tada, Hitoshi
    Suzuki, Toshio
    Habuchi, Tomonori
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 66 (02) : 207 - 214
  • [2] Influence of CYP3A5 Polymorphisms On Tacrolimus Pharmacokinetics and Renal Function in Renal Transplant Recipients.
    Salvador-Garrido, P.
    Outeda-Macias, M.
    Pedreira-Vazquez, I.
    Elberdin-Pazos, L.
    Fernandez-Rivera, C.
    Alonso-Hernandez, A.
    Martin-Herranz, I.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 618 - 618
  • [3] Influence of CYP3A5 Polymorphisms On Tacrolimus Pharmacokinetics and Renal Function in Renal Transplant Recipients.
    Salvador-Garrido, P.
    Outeda-Macias, M.
    Pedreira-Vazquez, I.
    Elberdin-Pazos, L.
    Fernandez-Rivera, C.
    Alonso-Hernandez, A.
    Martin-Herranz, I.
    TRANSPLANTATION, 2014, 98 : 618 - 618
  • [4] Effects of CYP3A5 Genetic Polymorphism on the Pharmacokinetics of Tacrolimus in Renal Transplant Recipients
    Mac Guad, R.
    Zaharan, N. L.
    Chik, Z.
    Mohamed, Z.
    Peng, N. K.
    Adnan, W. A. H. W. M.
    TRANSPLANTATION PROCEEDINGS, 2016, 48 (01) : 81 - 87
  • [5] Pharmacogenetics of CYP3A4, CYP3A5, CYP2C8 and CYP2C19 and Their Influence on Tacrolimus Pharmacokinetics in Renal Transplant Recipients.
    Wang, Z.
    Han, Z.
    Tao, J.
    Chen, H.
    Sun, L.
    Tan, R.
    Gu, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 672 - 672
  • [6] Pharmacogenetics of Immunosuppressant Polymorphism of CYP3A5 in Renal Transplant Recipients
    Larriba, J.
    Imperiali, N.
    Groppa, R.
    Giordani, C.
    Algranatti, S.
    Redal, M. A.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (01) : 257 - 259
  • [7] Association of CYP3A5*3*6*7 Metabolic Composites to Tacrolimus Pharmacokinetics in African American and Caucasian Renal Transplant Recipients.
    Tornatore, K.
    Brazeau, D.
    Meaney, C.
    Attwood, K.
    Wilding, G.
    Chang, S.
    Venuto, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 496 - 496
  • [8] Influence of CYP3A5 polymorphisms on 5-year tacrolimus pharmacokinetics and renal function in renal transplant recipients
    Salvador, Pilar
    Outeda, Maria
    Pedreira, Isaura
    Fernandez, Constantino
    Alonso, Angel
    Martin, Isabel
    TRANSPLANTATION, 2016, 100 (07) : S710 - S710
  • [9] Tacrolimus Population Pharmacokinetics and Multiple CYP3A5 Genotypes in Black and White Renal Transplant Recipients
    Campagne, Olivia
    Mager, Donald E.
    Brazeau, Daniel
    Venuto, Rocco C.
    Tornatore, Kathleen M.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (09): : 1184 - 1195
  • [10] TACROLIMUS POPULATION PHARMACOKINETICS AND CYP3A5 GENOTYPES IN AFRICAN AMERICAN AND CAUCASIAN RENAL TRANSPLANT RECIPIENTS
    Campagne, O.
    Mager, D. E.
    Brazeau, D.
    Venuto, R. C.
    Tornatore, K. M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S7 - S7
12345